GJB2 and cancer: Therefore, we investigated the clinical significance of GJB2-positive CAFs in cancer by measuring the GJB2 signature score in 8469 cancer tissues from The Cancer Genome Atlas (Fig. 5c and Supplementary Fig. S6a).